Quantcast

Latest Lipids Stories

2014-05-07 12:30:30

WOODBRIDGE, ON, May 7, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that the U.S. Patent and Trademark Office (USPTO) has issued Patent Number 8,715,648 titled "Formulations Comprising Omega-3 Fatty Acids and Anti-Obesity Agent for the Reduction of Body Weight in Cardiovascular Disease Patients (CVD) and Diabetics"....

2014-05-06 16:31:55

WOODBRIDGE, ON, May 6, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that it presented two posters at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions held in Toronto, Ontario, Canada, May 1-3, 2014. Both posters discussed Omega-3 deficiency (OM3D)...

2014-05-05 08:27:56

SBIR Grant from the National Institutes of Neurological Diseases and Stroke Provides Funds for IND-enabling Studies of Lpathomab SAN DIEGO, May 5, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, received official notification from the National Institutes of Neurological Diseases and Stroke (NINDS) that it has been awarded a $1.7 million, 2.5-year grant to develop its antibody therapeutic, Lpathomab(TM), which is directed...

2014-05-01 16:31:22

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that it will be presenting two posters at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions in Toronto, Ontario, Canada, May 1-3, 2014. The first poster entitled "Correlation...

2014-05-01 16:31:16

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announces a correction to its press release issued yesterday entitled "Pivotal Therapeutics Announces 2013 Financial Results". The decrease in the loss from 2012 to 2013 of $745,342 was inadvertently overstated by $91,520. The correct decrease in loss is $653,822 and...

2014-04-30 20:24:05

WOODBRIDGE, ON, April 30, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the fiscal year ended December 31, 2013. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated. Financial Review Sales for the year ended 2013 totaled $303,530 versus...

2014-04-30 10:18:48

More research is needed to better understand the important role that dietary fats play in optimal health, said a panel of leading food and nutrition scientists Friday at an American Society for Nutrition (ASN) pre-annual meeting session. More than 130 academic and industry food and nutrition scientists and registered dietitians attended the half-day ASN Satellite Symposium: Let's Chew the Fat: Current Thinking on Dietary Fats and the Food We Eat, held from 1-5 pm at the San Diego Bayfront...

2014-04-23 20:23:03

WOODBRIDGE, ON, April 23, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced the resignations of two of its directors effective April 17, 2014: Dr. John P. Nicholson, Jr. who was appointed on October 30, 2013 following the conclusion of an equity financing, and Mr. James Connolly, who was appointed March 10, 2014 following the closing of...

2014-04-22 12:32:57

Setting Record Straight on Unique Plant's Healthy Oil CHICAGO, April 22, 2014 /PRNewswire/ -- Canola oil is widely regarded as heart-healthy and versatile by health professionals and chefs, but some consumers may not understand why - or know what canola is in the first place. http://photos.prnewswire.com/prnvar/20140421/76820 "Canola is often confused with rapeseed, but the two crops and their oils are distinctly different both compositionally and nutritionally," explains...

2014-04-10 23:24:53

Health Nutrition News explains why lowering triglycerides are important for heart health and discusses how to lower triglycerides using the right kind of omega-3 supplements. Boston, MA (PRWEB) April 10, 2014 Health Nutrition News has a new video in which they discuss triglycerides (TG), how they are important to human life, and are the main form of fat in the body. When the body has extra triglycerides, they are stored in different places, such as the hips and belly, in case they are...


Latest Lipids Reference Libraries

Vistive Gold
2013-10-02 12:54:36

Vistive Gold, MON 87705, is a genetically engineered variety of glyphosate-resistant low-linolenic, high-oleic soybeans created by Monsanto. Vistive Gold was designed to be a replacement for hydrogenated oils and fats, which are high in trans-fatty acids. The decreased linolenic content enables Vistive Gold to have favorable traits for deep frying and increasing the shelf life of foods. The Federal Register declared on June 28, 2011 that Monsanto was petitioning the Animal and Plant...

More Articles (1 articles) »
Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related